![Bill E. Weiser](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Bill E. Weiser
Nessuna posizione attualmente
Profilo
Bill E.
Weiser worked as a General Manager-Pharmaceuticals at Liquidia Technologies, Inc., a Principal at Magellan Laboratories, Inc. and The Burroughs Wellcome Fund, and as a Vice President-Analytical Chemistry at Catalent Pharma Solutions, Inc. He received his undergraduate degree from The College of William & Mary and his doctorate from Purdue University.
Precedenti posizioni note di Bill E. Weiser
Società | Posizione | Fine |
---|---|---|
The Burroughs Wellcome Fund
![]() The Burroughs Wellcome Fund Investment Trusts/Mutual FundsMiscellaneous The Burroughs Wellcome Fund is a private foundation located in Research Triangle Park, NC. The private company's mission is to serve and strengthen society by nurturing a diverse group of leaders in biomedical sciences to improve human health through education and powering discovery in frontiers of greatest need. The CEO of the company is Louis J. Muglia. | Corporate Officer/Principal | - |
Catalent Pharma Solutions, Inc.
![]() Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | Corporate Officer/Principal | - |
Magellan Laboratories, Inc.
![]() Magellan Laboratories, Inc. BiotechnologyHealth Technology Part of Cardinal Health, Inc., Magellan Laboratories, Inc. provides product development services of biological products. The company is based in Morrisville, NC. Magellan Laboratories was acquired by Cardinal Health, Inc. on March 18, 2002. | Corporate Officer/Principal | - |
Liquidia Technologies, Inc.
![]() Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Corporate Officer/Principal | - |
Formazione di Bill E. Weiser
Purdue University | Doctorate Degree |
The College of William & Mary | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 4 |
---|---|
Liquidia Technologies, Inc.
![]() Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Health Technology |
Catalent Pharma Solutions, Inc.
![]() Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | Health Technology |
Magellan Laboratories, Inc.
![]() Magellan Laboratories, Inc. BiotechnologyHealth Technology Part of Cardinal Health, Inc., Magellan Laboratories, Inc. provides product development services of biological products. The company is based in Morrisville, NC. Magellan Laboratories was acquired by Cardinal Health, Inc. on March 18, 2002. | Health Technology |
The Burroughs Wellcome Fund
![]() The Burroughs Wellcome Fund Investment Trusts/Mutual FundsMiscellaneous The Burroughs Wellcome Fund is a private foundation located in Research Triangle Park, NC. The private company's mission is to serve and strengthen society by nurturing a diverse group of leaders in biomedical sciences to improve human health through education and powering discovery in frontiers of greatest need. The CEO of the company is Louis J. Muglia. | Miscellaneous |
- Borsa valori
- Insiders
- Bill E. Weiser